UNITY Biotechnology Reports Granting of New Employment Inducement Awards
February 03 2021 - 8:00AM
UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology
company developing therapeutics to slow, halt or reverse diseases
of aging, today announced that from January 19, 2021 through
February 2, 2021, the Board of Directors (the “Board”) granted 4
new employees stock-based awards covering an aggregate of 453,000
shares of UNITY common stock, including options to purchase an
aggregate of 453,000 shares of UNITY common stock. The stock-based
awards were granted pursuant to the UNITY 2020 Employment
Inducement Incentive Plan, as amended, which was approved by the
Board in March 2020 to provide for grants to newly hired employees
as a material inducement for them to commence employment with UNITY
in accordance with Nasdaq Stock Market Rule 5635(c)(4).
About UNITYUNITY is developing a new class of
therapeutics to slow, halt or reverse diseases of aging. UNITY’s
current focus is on creating medicines to selectively eliminate or
modulate senescent cells and thereby provide transformative benefit
in age-related ophthalmologic and neurologic diseases.
More information is available
at www.unitybiotechnology.com or follow us
on Twitter and LinkedIn.
Media
Canale Communications
Jason Spark
jason.spark@canalecomm.com
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Aug 2024 to Sep 2024
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Sep 2023 to Sep 2024